The Mochudi Prevention Project ART Protocol

Condition:   HIV InfectionsIntervention:   Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, EmtricitabineSponsors:   Harvard School of Public Health;   National Institute of Allergy and Infectious Diseases (NIAID)Terminated - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials